《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2011年 > 3期

葛根素治疗糖尿病合并颈动脉硬化患者细胞黏附分子和炎症因子的改变及临床意义

来自:中国糖尿病资讯网  编辑:admin|点击数:|2011-10-20

  ·糖尿病中医药治疗研究·

  熊燕 张太阳 赖晓阳

  作者单位: 330006南昌,南昌大学第二附属医院内分泌科(熊燕、赖晓阳); 南昌市中西医结合医院内分泌科(张太阳)

  通讯作者:张太阳,E-mail: zhangtaiyang666@126.com

  【摘要】 目的 探讨葛根素治疗2型糖尿病(T2DM)合并颈动脉硬化的作用机制。 方法 将80例T2DM合并颈动脉硬化患者分为葛根素治疗组和对照组,比较两组患者治疗前后血液流变学、可溶性细胞间黏附分子1(sICAM-1)、可溶性血管细胞黏附分子1(sVCAM-1)及高敏C反应蛋白(hsC-RP)的变化。 结果 葛根素治疗组经治疗后血液流变学各项指标均有下降(P<0.05); sICAM-1、sVCAM-1、hsC-RP水平明显下降 (P<0.01) ,且明显优于对照组(P<0.05);而对照组治疗前后各项指标差别均无显著性意义(P>0.05)。 结论 葛根素能改善T2DM合并颈动脉硬化患者的血液流变学,调节改善免疫细胞黏附分子和炎症因子表达,对血管有保护作用。

  【关键词】葛根素;黏附分子;高敏C反应蛋白;糖尿病; 颈动脉硬化

  doi:10.3969/j.issn.1006-6187.2011.03.009

  Effects of puerarin treatment on the levels of sVCAM-1 and hsCRP and their clinical significances in diabetic patients with carotid atherosclerosis

  XIONG Yan, ZHANG Tai-yang, LAI Xiao-yang. Department of Endocrinology, The Second Affiliated Hospital of Nanchang University,Nanchang 330006,China

  Corresponding author: ZHANG Tai-yang, E-mail: zhangtaiyang666@126.com

  【Abstract】 Objective To explore effects of puerarin on the levels of soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1) and high sensitive C-reactive protein (hsC-RP) and their clinical significance in DM patients with carotid atherosclerosis (CA). Methods 80 T2DM patients with CA were divided into puerarin group and control group. sICAM-1, sVCAM-1 and hsC-RP were determined by ELISA and compared between the two groups after treatment. Results The puerarin group had a lower levels of sICAM-1, sVCAM-1, hsC-RP and hemorrheologic parameters than control group (all P<0.05) after treatment. Conclusions Puerarin can improve hemorrheology, regulate the cell adhesion molecules and control the inflamation, which has a protective role in diabetic vascular disease.

  【Key words】Puerarin; Adhesion molecules; Hypersensitivity C-reactive protein;Diabetes; Carotid atherosclerosis

上一篇:糖敏灵丸对2型糖尿病合并代谢综合征患者β细胞功能的影响 下一篇:葛根素对2型糖尿病肾病疗效的影响